These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22539107)

  • 1. Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ.
    Irie K; Yanagita RC; Nakagawa Y
    Med Res Rev; 2012 May; 32(3):518-35. PubMed ID: 22539107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple analogue of tumor-promoting aplysiatoxin is an antineoplastic agent rather than a tumor promoter: development of a synthetically accessible protein kinase C activator with bryostatin-like activity.
    Nakagawa Y; Yanagita RC; Hamada N; Murakami A; Takahashi H; Saito N; Nagai H; Irie K
    J Am Chem Soc; 2009 Jun; 131(22):7573-9. PubMed ID: 19449873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activities of simplified analogs of the natural PKC ligands, bryostatin-1 and aplysiatoxin.
    Irie K; Yanagita RC
    Chem Rec; 2014 Apr; 14(2):251-67. PubMed ID: 24677503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1.
    Lorenzo PS; Bögi K; Hughes KM; Beheshti M; Bhattacharyya D; Garfield SH; Pettit GR; Blumberg PM
    Cancer Res; 1999 Dec; 59(24):6137-44. PubMed ID: 10626804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The catalytic domain of protein kinase Cdelta confers protection from down-regulation induced by bryostatin 1.
    Lorenzo PS; Bögi K; Acs P; Pettit GR; Blumberg PM
    J Biol Chem; 1997 Dec; 272(52):33338-43. PubMed ID: 9407126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
    Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
    Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
    Levine BL; May WS; Tyler PG; Hess AD
    J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bryostatin-I: a dendritic cell stimulator for chemokines induction and a promising adjuvant for a peptide based cancer vaccine.
    Yan W; Chen WC; Liu Z; Huang L
    Cytokine; 2010 Dec; 52(3):238-44. PubMed ID: 20869878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bryostatin-1 enhances the maturation and antigen-presenting ability of murine and human dendritic cells.
    Do Y; Hegde VL; Nagarkatti PS; Nagarkatti M
    Cancer Res; 2004 Sep; 64(18):6756-65. PubMed ID: 15374994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C.
    Isakov N; Galron D; Mustelin T; Pettit GR; Altman A
    J Immunol; 1993 Feb; 150(4):1195-204. PubMed ID: 8432975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity studies on the spiroketal moiety of a simplified analogue of debromoaplysiatoxin with antiproliferative activity.
    Kikumori M; Yanagita RC; Tokuda H; Suzuki N; Nagai H; Suenaga K; Irie K
    J Med Chem; 2012 Jun; 55(11):5614-26. PubMed ID: 22625994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of protein kinase C isozymes involved in the anti-proliferative and pro-apoptotic activities of 10-Methyl-aplog-1, a simplified analog of debromoaplysiatoxin, in several cancer cell lines.
    Hanaki Y; Shikata Y; Kikumori M; Hotta N; Imoto M; Irie K
    Biochem Biophys Res Commun; 2018 Jan; 495(1):438-445. PubMed ID: 29129688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bryostatin-1 causes radiosensitization of BMG-1 malignant glioma cells through differential activation of protein kinase-Cδ not evident in the non-malignant AA8 fibroblasts.
    Dagur RS; Hambarde S; Chandna S
    Mol Cell Biochem; 2015 Mar; 401(1-2):49-59. PubMed ID: 25472878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and biological activities of bryostatins from Japanese bryozoan.
    Ueno S; Yanagita RC; Murakami K; Murakami A; Tokuda H; Suzuki N; Fujiwara T; Irie K
    Biosci Biotechnol Biochem; 2012; 76(5):1041-3. PubMed ID: 22738985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective versus tumorigenic protein kinase C activators.
    Nelson TJ; Alkon DL
    Trends Biochem Sci; 2009 Mar; 34(3):136-45. PubMed ID: 19233655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of long-term cognitive-enhancing effects of bryostatin-1 on the rabbit (Oryctolagus cuniculus) nictitating membrane response.
    Wang D; Darwish DS; Schreurs BG; Alkon DL
    Behav Pharmacol; 2008 May; 19(3):245-56. PubMed ID: 18469542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human T lymphocytes by bryostatin.
    Hess AD; Silanskis MK; Esa AH; Pettit GR; May WS
    J Immunol; 1988 Nov; 141(10):3263-9. PubMed ID: 3263418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
    Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bryostatin 1 acts synergistically with interleukin-1 alpha to induce secretion of G-CSF and other cytokines from marrow stromal cells.
    Lilly M; Vo K; Le T; Takahashi G
    Exp Hematol; 1996 Apr; 24(5):613-21. PubMed ID: 8605966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activities of the amide derivative of aplog-1, a simplified analog of aplysiatoxin with anti-proliferative and cytotoxic activities.
    Hanaki Y; Yanagita RC; Sugahara T; Aida M; Tokuda H; Suzuki N; Irie K
    Biosci Biotechnol Biochem; 2015; 79(6):888-95. PubMed ID: 25612633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.